Dittmar G
Neurologische Klinik der Städtischen Kliniken Dortmund.
Med Klin (Munich). 1991 Dec 15;86(12):607-12.
Alcohol-induced delirium tremens (DT) is a well-known disease with an unpredictable, either favorable or fatal, spontaneous course. The cardinal symptoms are disorientation, hallucinations and autonomic lability. The pathogenesis of DT is still unknown, and the numerous hypothesis have spawned as many therapeutic approaches. Drugs with a cross-tolerance to alcohol have so far proved best. Benzodiazepines and clomethiazole have been considered the drugs of first choice for the past 20 years and more. Improvements in intensive care has helped lower the mortality rate to 3 to 8%. Major tranquilizers with a strong antipsychotic effect and anti-epileptic agents can effectively expand the sedative management of DT. Cerebral convulsions at the beginning of DT appear to dispose the patient to a prolonged course, and preexisting or concomitant disease affecting other organs (complicated DT) clearly prolongs the duration of delirium. The risks and contraindications of clomethiazole are emphasized. The course and outcome of DT is unpredictable--in our patients we found a mortality rate of 3.7% and 12.3% end up in a defective state.
酒精性震颤谵妄(DT)是一种众所周知的疾病,其自发病程不可预测,预后可能良好,也可能致命。主要症状为定向障碍、幻觉和自主神经功能不稳定。DT的发病机制尚不清楚,众多假说催生了许多治疗方法。迄今为止,对酒精有交叉耐受性的药物被证明是最佳选择。在过去20多年里,苯二氮䓬类药物和氯美噻唑一直被视为首选药物。重症监护的改善已帮助将死亡率降至3%至8%。具有强大抗精神病作用的强效镇静剂和抗癫痫药物可有效扩展DT的镇静治疗。DT开始时出现的脑惊厥似乎会使患者病程延长,而影响其他器官的既往或伴随疾病(复杂性DT)显然会延长谵妄持续时间。文中强调了氯美噻唑的风险和禁忌证。DT的病程和结局不可预测——在我们的患者中,我们发现死亡率为3.7%,12.3%的患者最终处于残疾状态。